Radiofrequency Ablation Devices Market Size - By Product Type (RF Generators, Consumables), By Application (Oncology, Cardiology, Cosmetic Surgery, Gynecology, Pain Management, Urology), By End-Use – Global Forecast (2023-2032)
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationRadiofrequency Ablation Devices Market Size
Radiofrequency Ablation Devices Market size was valued at USD 4.3 billion in 2022 and is estimated to account for USD 10.4 billion by 2032. Radiofrequency ablation is a medical technique that involves using high-frequency electrical currents to generate heat and target specific tissues in the body.
These devices are utilized to create controlled lesions or destroy abnormal tissue growths without the need for traditional open surgery. The radiofrequency ablation procedure is typically performed using specialized catheters or probes that deliver the radiofrequency energy to the intended area. The market is witnessing lucrative expansion because of the increasing prevalence of chronic diseases, rising demand for minimally invasive treatments, and advancements in medical technology. These devices offer several advantages, such as reduced patient recovery time, decreased risk of complications, and improved treatment outcomes.
Advancements in RF ablation technology will enhance the development of sophisticated and precise devices. As, modern RF ablation devices can accurately target specific tissues, tumors, or nerves, while minimizing damage to surrounding healthy tissues. This increased precision has improved treatment outcomes and reduced the risk of complications. Furthermore, the miniaturization of RF ablation devices and the development of more flexible and maneuverable catheters that provide ease of use for healthcare providers to access challenging anatomical locations, perform complex procedures, and improve patient comfort during the treatment.
Moreover, the integration of RF ablation devices with advanced medical imaging technologies such as ultrasound, CT scans, and MRI allows real-time visualization of the treatment area, enhancing accuracy and providing immediate feedback to the medical team during the procedure. Additionally, RF ablation devices offer multiple treatment modalities, combining radiofrequency energy with other techniques including microwave ablation or cryoablation for precise disease treatment.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Radiofrequency Ablation Devices Market Size in 2022 | USD 4.3 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 8.9% |
| 2032 Value Projection | USD 10.4 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 267 |
| Tables, Charts & Figures | 347 |
| Segments covered | Product, Application, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
COVID-19 Impact
When COVID-19 hit, it was a major blow to the market for devices used to remove tumors without surgery. Hospitals were swamped with COVID patients, so they had to put off or even cancel non-urgent procedures like radiofrequency ablation. This was a big setback for people needing treatment for non-life-threatening tumors. The pandemic also messed with supply chains, making it harder to get the materials and equipment needed to build these devices. On top of that, many companies had to focus on developing things like COVID tests and ventilators instead.
Radiofrequency Ablation Devices Market Trends
The growing prevalence of chronic diseases such as cancer, cardiovascular devices, gynecological disorders, diabetes, and several others is a key factor driving the industry progression. The increasing prevalence rate of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia with an aging population base will offer unprecedented expansion opportunities to the industry gains. For instance, the World Health Organization (WHO) reports that more than 17.9 million deaths globally each year are attributed to cardiovascular disorders, that stands for around 32% of overall mortality worldwide.
Also, the Centers for Disease Control and Prevention (CDC) estimated that 12.1 million people will suffer from atrial fibrillation by 2030 in the U.S. owing to the increase in number of heart disorders, the demand for radiofrequency ablation devices for cardiac ablation. Further, radiofrequency ablation is commonly used in the treatment of cancerous tumors, particularly in the liver, kidney, lung, and bone. For instance, according to the World Health Organization (WHO) estimates, cancer is one of the leading causes of death in the majority of countries globally.
Radiofrequency Ablation Devices Market Analysis
The radiofrequency ablation devices market by product type is segregated into RF generators and consumables. The RF generators garnered more than USD 2.9 billion in revenue size in the year 2022. As the prevalence of chronic diseases such as cardiac arrhythmias, cancer, and chronic pain continues to rise globally, the demand for radiofrequency ablation procedures and consequently. Newer generations of RF generators are often equipped with advanced features such as real-time monitoring, impedance feedback systems, and optimized energy delivery algorithms, to enhance treatment outcomes and patient safety.
Radiofrequency ablation devices are used in many different medical fields, including cancer treatment, heart procedures, plastic surgery, women's health, pain relief, and urinary tract care. In 2022, the biggest slice of the market went to cardiology, which deals with heart conditions. This is mostly because of the growing number of people around the world with heart rhythm problems like atrial fibrillation and ventricular tachycardia. These problems are often caused by an aging population and health issues like high blood pressure and diabetes. As more people have heart rhythm problems, the demand for radiofrequency ablation devices is going up. This is because radiofrequency ablation is a common and effective way to treat these conditions. Doctors and cardiologists are also learning more about the benefits of radiofrequency ablation for heart rhythm problems, which is making it a more popular choice for treatment.
Based on end-use, the radiofrequency ablation devices market is subdivided into hospitals, ambulatory surgical centers, and others. The hospitals segment is predicted to witness the highest growth at 9.3% CAGR by 2032 attributed to the aging demographics, growing hospital admissions, and high prevalence rate of chronic diseases burden. Moreover, the growing adoption of minimally invasive treatment options owing to their benefits including shorter hospital stays, faster patient recovery, and reduced risk of complications among hospitals. Further, hospitals are implementing collaborative care models involving multidisciplinary teams, including cardiologists, oncologists, pain management specialists, and several other experts.
Radiofrequency ablation devices are seeing a huge demand in the US, with sales reaching $1.6 billion in 2022. The reason? The growing number of Americans suffering from chronic diseases like cancer, diabetes, and heart problems. These devices offer a precise and effective treatment for these conditions. Companies in the industry are also doing their part by constantly improving these devices, including ablation catheters and RF generators. They're also integrating them with medical imaging technology to create a more sophisticated approach to treatment. And let's not forget the shift towards value-based healthcare, where the focus is on patient outcomes and getting the most bang for your buck. This is making radiofrequency ablation a more attractive option for doctors and patients alike.
Radiofrequency Ablation Devices Market Share
Some of the prominent radiofrequency ablation devices market participants operating in the radiofrequency ablation devices industry include
- Avanos Medical, Inc.
- Stryker Corporation
- Abbott Laboratories, Inc.
- Medtronic, Plc.
- Boston Scientific Corporation
- Becton
- Dickinson and Company (Venclose, Inc.)
- AngioDynamics, Inc.
- Hologic, Inc.
- AtriCure, Inc.
- Koninklijke Philips N.V., Smith & Nephew
- Baylis Medical Company, Inc
- inomed Medizintechnik GmbH
- Sutter Medizintechnik GmbH
- Epimed International
Radiofrequency Ablation Devices Industry News
- In May 2023, Abbott Laboratories received approval for its TactiFlex ablation catheter by U.S. FDA. This advanced catheter is used with a next-gen RF ablation system for effective cardiac disease treatment such as atrial fibrillation and cardiac arrhythmia. Such approvals expanded the company’s product offerings in the significant market.
- In August 2022, Medtronic Plc. acquired Affera, Inc. Through this acquisition, Medtronic broadened its cardiac ablation product portfolio with a cardiac mapping and navigation platform with integration of radiofrequency and focal pulsed field ablation solutions to treat cardiac arrhythmia and atrial fibrillation.
Radiofrequency ablation devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Product Type (USD Million & Units)
- RF generators
- Consumables
By Application (USD Million)
- Oncology
- Cardiology
- Cosmetic surgery
- Gynecology
- Pain management
- Urology
- Others
By End-use (USD Million)
- Hospitals
- Ambulatory surgical centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy